Logo do repositório
 
Publicação

Influence of local and systemic antibiotics in non-surgical peri-implantitis treatment : a systematic review and meta-analysis update

datacite.subject.fosCiências Médicas::Ciências da Saúde
datacite.subject.sdg03:Saúde de Qualidade
dc.contributor.authorMeném, Madalena
dc.contributor.authorEstácio, Catarina
dc.contributor.authorMascarenhas, Paulo
dc.contributor.authorSantos, Alexandre
dc.date.accessioned2026-05-12T14:08:05Z
dc.date.available2026-05-12T14:08:05Z
dc.date.issued2025-11
dc.description.abstractBackground: Adjunctive antibiotics are frequently used alongside mechanical debridement (MD) for peri-implantitis, yet their additional clinical benefit remains uncertain. Objective: To systematically assess whether adding local or systemic antibiotics to non-surgical MD improves clinical outcomes in peri-implantitis. Methods: The review protocol was registered in PROSPERO (CRD42022380401). We included randomised controlled trials (RCTs) involving peri-implantitis patients treated with MD plus local or systemic antibiotics, compared to MD alone, with at least 3 months of follow-up. Searches were conducted in PubMed, Cochrane Library, LILACS, Web of Science, and Embase up to 9 April 2025. Eleven RCTs (634 patients) were included in the qualitative synthesis. The Cochrane RoB 2.0 tool evaluated the risk of bias. Random-effects meta-analyses of data from 10 studies, adjusting results to an equivalent 6-month follow-up time-frame, assessed treatment efficacy based on changes in probing pocket depth (PPD) and bleeding on probing (BoP), the primary outcomes. Meta-regressions examined the influence of mean patient age and implant-to-patient ratio on adjusted outcomes. Results: Systemic antibiotics resulted in generally greater PPD reduction and BoP reduction over MD alone or plus chlorhexidine, with the greatest benefits observed in amoxicillin-based multi-agent regimens and longer follow-up duration. Comparatively, local antimicrobial adjuncts performed less effectively on PPD reduction. No implant losses were reported, and adverse events were rare. Limitations: Some included trials had a high risk of bias and considerable heterogeneity. Follow-up was limited to the short term, and definitions of clinical “success” varied across studies. Conclusions: Adjunctive systemic antibiotics, particularly amoxicillin-based combinations, substantially improve short-term clinical outcomes of non-surgical peri-implantitis treatment compared to MD alone. Nevertheless, given the variability in study quality and potential risks associated with antibiotic use, their application should be judicious. Further long-term RCTs are warranted to confirm sustained efficacy and safety.eng
dc.identifier.citationMeném M, Estácio C, Mascarenhas P, Santos A. Influence of Local and Systemic Antibiotics in Non-Surgical Peri-Implantitis Treatment: A Systematic Review and Meta-Analysis Update. Applied Sciences. 2025; 15(21):11422. https://doi.org/10.3390/app152111422
dc.identifier.doi10.3390/app152111422
dc.identifier.issn2076-3417
dc.identifier.urihttp://hdl.handle.net/10400.26/63078
dc.language.isoeng
dc.peerreviewedyes
dc.publisherMDPI
dc.relation.hasversionhttps://doi.org/10.3390/app152111422
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectdental implants
dc.subjectperi-implantitis
dc.subjectperiodontitis
dc.subjectperi-implantitis therapy
dc.subjectperi-implantitis treatment
dc.titleInfluence of local and systemic antibiotics in non-surgical peri-implantitis treatment : a systematic review and meta-analysis updateeng
dc.typecontribution to journal
dspace.entity.typePublication
oaire.citation.issue21
oaire.citation.startPage11422
oaire.citation.titleApplied Sciences
oaire.citation.volume15
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85

Ficheiros

Principais
A mostrar 1 - 1 de 1
A carregar...
Miniatura
Nome:
Artigo_PMascarenhas_2025_03.pdf
Tamanho:
3 MB
Formato:
Adobe Portable Document Format
Licença
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
license.txt
Tamanho:
1.85 KB
Formato:
Item-specific license agreed upon to submission
Descrição: